William Andrew Macan net worth and biography

William Macan Biography and Net Worth

VP of Neuronetics

W. Andrew Macan has served as Neuronetics’ Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary since January 2020.

Prior to joining Neuronetics, Mr. Macan was Senior Vice President, General Counsel and Corporate Secretary of U.S. Silica Holdings, Inc., a Russell 2000 diversified minerals company, from October 2018 until January 2020. He served in roles of increasing responsibility with Axalta Coating Systems, LLC, from October 2013 until October 2018, most recently as General Counsel and Chief Compliance Officer, Americas, and The Chubb Corporation, from October 2003 until October 2013, including as Vice President, Corporate Counsel and Secretary for over 8 years.

Mr. Macan began his career in private practice at Ballard Spahr LLP and Dechert LLP. He earned a B.A. in Government from Franklin & Marshall College and his J.D. from Emory University School of Law with distinction and Order of the Coif.

What is William Andrew Macan's net worth?: The estimated net worth of William Andrew Macan is at least $1.99 million as of March 4th, 2025. Mr. Macan owns 526,805 shares of Neuronetics stock worth more than $1,986,055 as of March 31st. This net worth estimate does not reflect any other assets that Mr. Macan may own. Learn More about William Andrew Macan's net worth.
How do I contact William Andrew Macan?: The corporate mailing address for Mr. Macan and other Neuronetics executives is 3222 PHOENIXVILLE PIKE, MALVERN PA, 19355. Neuronetics can also be reached via phone at (610) 640-4202 and via email at ir@neuronetics.com. Learn More on William Andrew Macan's contact information.
Has William Andrew Macan been buying or selling shares of Neuronetics?: In the last ninety days, William Andrew Macan has sold $54,780.81 in Neuronetics stock. Most recently, William Andrew Macan sold 377 shares of the business's stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $4.48, for a transaction totalling $1,688.96. Following the completion of the sale, the executive vice president now directly owns 526,805 shares of the company's stock, valued at $2,360,086.40. Learn More on William Andrew Macan's trading history.
Who are Neuronetics' active insiders?: Neuronetics' insider roster includes Robert Cascella (Director), Sheryl Conley (Director), Stephen Furlong (CFO), Gregory Harper (VP), William Macan (VP), Bruce Shook (Director), and Keith Sullivan (CEO). Learn More on Neuronetics' active insiders.
Are insiders buying or selling shares of Neuronetics?: In the last twelve months, Neuronetics insiders bought shares 7 times. They purchased a total of 261,776 shares worth more than $277,669.60. In the last twelve months, insiders at the sold shares 12 times. They sold a total of 139,515 shares worth more than $430,285.36. The most recent insider tranaction occured on March, 4th when CFO Stephen Furlong sold 1,867 shares worth more than $8,364.16. Insiders at Neuronetics own 9.8% of the company. Learn More about insider trades at Neuronetics.
Information on this page was last updated on 3/4/2025.

William Andrew Macan Insider Trading History at Neuronetics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/4/2025	Sell	377	$4.48	$1,688.96	526,805
2/12/2025	Sell	12,175	$3.83	$46,630.25	388,647
2/10/2025	Sell	1,970	$3.28	$6,461.60	400,822
10/8/2024	Sell	1,541	$0.82	$1,263.62	402,792
2/28/2024	Sell	22,377	$3.16	$70,711.32	395,359
2/14/2024	Sell	15,621	$3.38	$52,798.98	417,736
2/6/2024	Sell	5,385	$3.39	$18,255.15	433,357
12/21/2023	Sell	11,663	$2.52	$29,390.76	348,742
12/19/2023	Sell	11,664	$2.24	$26,127.36	372,069
10/6/2023	Sell	1,469	$1.16	$1,704.04	383,733
7/11/2023	Sell	2,645	$2.13	$5,633.85	385,202
3/7/2023	Sell	12,692	$4.59	$58,256.28	387,847
2/7/2023	Sell	5,162	$5.99	$30,920.38	333,557
1/23/2023	Sell	16,046	$5.96	$95,634.16	338,719
10/10/2022	Sell	76	$2.82	$214.32	354,765
10/7/2022	Sell	1,547	$2.93	$4,532.71	354,841
7/8/2022	Sell	2,746	$3.60	$9,885.60	356,388
2/7/2022	Sell	4,716	$3.26	$15,374.16
1/24/2022	Sell	11,562	$3.52	$40,698.24
7/8/2021	Sell	2,591	$14.61	$37,854.51	210,491
3/10/2020	Buy	5,000	$2.00	$10,000.00	182,399

See Full Table

William Andrew Macan Buying and Selling Activity at Neuronetics

Neuronetics Company Overview

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Today's Range

Now: $3.77

$3.57

$4.00

50 Day Range

MA: $4.03

$2.24

$5.42

2 Week Range

Now: $3.77

$0.52

$5.92

Volume

1,720,939 shs

Average Volume

625,122 shs

Market Capitalization

$114.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.07